Replies to post #116994 on PharmaCyte Biotech Inc (PMCB)

[1234jklm]

Investors don’t need to approve another batch of shares. They have one golden share to do that

[DragonBear]

I don't see investors approving another batch of shares

Investors have no control over how many private placements Kenny offers up. Kenny and his boyz can dilute the stock out the wing-wang, and SHs have no voice in the matter.

Also don't leave out they can at any time grant themselves stock options at a given exercise price they determine. From the last 10K:

As of April 30, 2019, the Company had 107,450,000 outstanding stock options to its directors and officers (collectively, “Employee Options”) and consultants (“Non-Employee Options”).

Some of those expire 03-Mar at an exercise price of 0.11. Easily replaced with new ones having an exercise price of 0.01, or lower. It's up to Kenny and his boyz.

The problem is the share total. It has gotten too large and they are still selling blocks of shares cheap which is undercutting our investment.

Remember that thought, the next time someone posts all biotechs undergo dilution to an implied O/S 1.4B (they don't).

Dilution in a Microcrap is never a problem, until after it happens.